We discuss, from an industrial point of view, the scope and possibilities of recombinant DNA technology for "diagnostic enzyme" production and application. We describe the construction of enzyme-overproducing strains and show how to simplify downstream processing, increase product quality and process profitability, improve diagnostic enzyme properties, and adjust enzymes to harsh assay conditions. We also consider some safety and environmental aspects of enzyme production. Other aspects of diagnostic enzymes that we cover are the facilitation of enzyme purification by attachment of short amino acid tails, the introduction of tails or tags for site-specific conjugation or oriented immobilization, the construction of bi-or multifunctional enzymes, and the production of enzyme-based diagnostic tests as demonstrated by the homogeneous immunoassay system of CEDL#{174} tests. -galactosidase, and alkaline phosphatase are the most commonly used enzyme labels.
genase (G6P-DH) can be used to measure glucose ( Table  1 , reaction 2).2 A system that involves more than two enzymes is exemplified for the determination of creatinine (Table 1, 4-MP, 4-aminoantipynne; TBHB,2,4,6-tribromo-3-hydroxybenzoic acid.
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Immobilized Enzymes
Immobilized enzymes have mainly found application in enzyme-electrode and dry reagent products. These devices are most commonly used for glucose monitoring, with glucose oxidase being used as the enzyme. Enzyme electrodes (4) 
Enzyme-Based

Signal and Target Amplification
Enzymes are used for signal and target amplification to improve the sensitivity and speed of immunoassays or to enable the multiplication of nucleic acid fragments.
Signal amplification
by a second enzyme depends on a coupled substrate or cofactor cycle that is catalytically activated by an enzyme label (7, 8) . The principle of enzyme amplification is illustrated in Fig. 2 , in which alkaline phosphatase is used as the primary enzyme label for the AMPAK system (Novo BioLabs, Cambridge, UK). In this system, NADP, an alkaline phosphatase substrate, is dephosphorylated to NAD, which activates a coupled redox cycle involving an alcohol dehydrogenase and diaphorase reaction for the continuous generation of a purple formazan product.
In contrast to signal amplification, target amplifica- For the production of a naturally secreted enzyme, or NADP as cofactor, in contrast to yeast G6P-DH, which is specific for NADP. 
G6P-DH from
Glucose Oxidase
The enzyme GOD from A. niger has found wide application (a) in the preservation of food (e.g., in the removal of oxygen from beverages, as an antioxidant, and in the removal of residual glucose from dried egg products), nidulans, and Saccharomyces cerevisiae (41) (42) (43) . The GOD gene was cloned from A niger genomic and cDNA libraries in a way similar to that described above for
G6P-DH.
Homologous and heterologous expression and secretion of GOD were studied in Aspergillus and Saccharomyces. A plasmid containing the GOD gene, including the natural GOD promoter with its regulatory properties, was reintroduced intoA niger to increase the GOD gene dosage by genomic integration. The best transformants produced about six times as much GOD as the parent strain (43) . However, the natural host organism did not prove to be ideal for GOD overexpression.
First, GOD expression and secretion depends on the presence of glucose and a pH of the culture medium >4.5. GOD production leads to gluconic acid and hydrogen peroxide formation and hence complicates cell culture. These problems can probably be circumvented by substituting the natural GOD promoter with another potent and glucose-independent Aspergillus promoter. Second, GOD is usuallycell associated, thus making purification more difficult.
Third, purified Aspergillus GOD is often contaminated with host cell enzymatic impurities such as catalase, amylase, and cellulase, which interfere with its application. To overcome these disadvantages, GOD expression and secretion were studied in S. cereuisiae. The mature GOD coding sequence was fused in frame with the yeast a-factorprepro sequence or the natural GOD signal sequence and then inserted into episomal replicating 2-gm DNA-based multicopy vectors under the control of a potent and tightly regulated yeast promoter (42). Derepression of the hybrid promoter leads to the secretion of large amounts of active GOD into the culture medium (up to 3 g/L) in a fermenter (44) (Fig. 4) .
Increased thermostabiity was even found for the core-like glycosylated yeast-derived GOD, as demonstrated by differential scanning calorimetry, which indicated increased melting points (Tm, Table 6 ). Furthermore, the yeast ngd29 mutant-derived GOD enzyme was almost as stable as chemically cross-linked A. ni- These results show that GOD is an excellent example for demonstrating the value of (a) different host organisms in improving production process (enzyme yield) and enzyme quality (free of interfering enzyme impurities) and (b) genetically modified host strains (mutants) in improving the enzymatic properties of an enzyme by altered posttranslational modification.
Human Placental Alkaline Phosphatase (PLAP)
Besides E. coli (3- Table 7 .Currently, this strategyseems very promising, not only for the production of eukaryotic alkaline phosphatases, but also for enzymes that cannot be expressed in microbial host organisms in the active form.
Enzyme Extensions and Fused Enzymes
If the hurdles of gene cloning and gene expression of an enzyme have been overcome, it is feasible to alter the nature of an enzyme molecule in a modest amount of time by genetic engineering techniques to give it special properties such as (a) a fused polypeptide tail to aid purification, covalent modification, or immobilization and (b) fusion of a second structural gene (enzyme).
Tails and Tags for Purification
The concept of purification fusions is based on (a) the affinity of the polypeptide tag for a biospecific ligand, enabling efficient purification of the fusion protein by affinity chromatography, or (b) changed physical properties of the fused polypeptide that make efficient purification possible by covalent chromatography, hydrophobic The advantages and disadvantages of the different tails and their potential in laboratory and industrialscale applications have been the topic of several reviews (58) (59) (60) (61) .
We therefore focus on the choice and application of those tails that may be most useful for the economic production of diagnostic enzymes.
Generally, the tails most attractive for the production of diagnostic enzymes (a) do not interfere with expression; (b) bind with high affinity and selectivity to a cheap adsorbent; (c) do not interfere with the enzymatic activity or substrate specificity; (d) alter the physical properties of the enzyme molecule as little as possible, and hence (e) can be left on after purification. These criteria are only more or less fulfilled by the available tails.
Hydrophobic and covalent tails usually do not have the selectivity needed for efficient recovery of a protein, especially for one-step purification.
Affinity tails based on an antigenic epitope suitable for immunoaflinity purification may, for economic reasons, be attractive only for laboratory-scale production or high-value diagnostic enzymes.
The eight-amino acid Flag peptide lower-cost techniques based on ion-exchange, and we are therefore studying thisapproach.
Poly(Arg) Tails to Yeast a-Glucosidaseand A. niger GOD
A positively charged tail of six arginine residues was attached to the COOH terminus of a-glucosidase (21, 63) . This raised the isoelectric point of natural a-glucosidase from 5.6 to >8 for a-glucosidase-(Arg)6, permitting efficient one-step cation-exchange purification.
Furthermore, the (Arg)6 tail could be removed by treatment with carboxypeptidase B. However, this approach proved limited, mainly because of partial proteolytic degradation of the tail by endo-and carboxypeptidases already acting on the tail during cell growth and during protein purification. This was observed in both E. coli and wild-type yeast cells. In addition, the instabifity in E. coli of plasmids with a poly(Arg)-tail has been noted by other groups (58, 64) . yeast strains leads to partial to complete removal of the (Arg)6 tail, this removal probably being caused by proteases of the yeast secretory pathway that are needed for natural prepro a-factor processing.These include KEX2 endoprotease,which is specific for adjacent basic amino acids (Lys and Arg), and KEX1, a carboxypeptidase that cleaves COOH-terminal Arg and Lys residues (65) . This problem may be completely solved by the construction and use of a yeast mutant strain lacking the proteases KEX1 and KEX2. In summary, the use of tails consisting of Arg or Lys residues with a positive charge may usually be difficult. However, COOH-terminal extensions interfered with the enzymatic activity of PyOD and caused about a fivefold decrease in specific enzymatic activity. Hence, in a second step, a (His)3 tail was engineered to the NH2-terminus of PyOD. The Met(His)3-PyOD retained the same enzymatic properties as the natural PyOD and was accessible to efficient metal affinity purification. However, the Met(His)3-PyOD enzyme was not as efficiently expressed as the natural PyOD. Therefore, in a third step, the NH2-terminal part of Met(His)3-PyOD was varied. An optimum NH2-terminal poly(His) tail with respect to efficient translation initiation (overexpression), accessibility to affinity purification, and specific enzymatic activity was constructed by insertion of three additional
Yeast mutant strains lacking endoproteinases
Poly(His) Tails Designedfor Metal AffinityPurification of
His residues adjacent to the Met residue at amino acid position 3 of natural PyOD (Table 8 ).
Poly(His)-tagged
GOD is another example of the recovery of a secreted enzyme by the poly(His) tail fusion technique.
The attachment of four His residues to the COOH terminus of GOD had no effect on expression or secretion, and the enzymatic propertiesof GOD-(His)4 approach those of wild-type GOD. GOD-(His)4 was recovered directly from the culture medium to >98% homogeneity by using either Zn2-iminodiacetate or Ni2-nitrilotriacetate adsorbents and an imidazole gradient ranging from 0 to 100 mmol/L for elution. p.gfL, and 9 x iO-' mol, respectively. The sensitivity obtained for the estimation of insulin was close to that of commercial insulin ELISAs, thus indicating the potential of this approach. However, the marker enzymes used are not ideal with respect to subunit structure, size, and specific activity (E. coli 3-galactosidase: homotetramer, 465 kDa, 600 kU/g; E. coli alkaline phosphatase:
Tails and Tags for
homodimer, 95 kDa, 50 kU/g, and Vibrio harveyi luciferase: heterodimer). enzymatic and genetic point of view, a  marker enzyme should be (a) small, (b) stable, and (c)  monomeric, and (d) should exhibit a high specific activity In this context, homodimeric eukaryotic 1k2l1ine phosphatases and monomeric horseradish peroxidase (74) are promising enzyme candidates because of their high stability and specific activity (up to 3000 kU/g and 2000 kU/g, respectively).
From the
Multifunctional Enzymes Made by Gene Fusion
In enzymatic analysis most assays are based on two or more enzymes (Table 1) . Therefore, with respect to enzyme production, it seems economically advisable and attractive to join the "free" serially operating enzymes by genetic means and then produce only one multienzyme protein instead of two or several. The feasibility of this concept is supported by naturally occurring hi-and multifunctional enzymes (75) such as tryptophan synthase and the two multifunctional subunits of the yeast fattyacid synthetase complex. The most suitable order for two synthetically fused structural genes at either the NH2 or COOH terminus with respect to the encoded bifunctional enzyme must be determined experimentally.
In this system the translational stop codon of the first gene is removed and replaced by a short peptide linker. The peptide linker may be designed according to the proposals of Argos (76), which rely on naturally occurring interdomain linkers of proteins of known three-dimensional structure.
Depending on the subunit structure of the natural enzymes (monomeric, dimeric, oligomeric, or heteromeric), the theoretically expected subunit interactions of an artificial bifunctional enzyme can range from monomeric to highly complex aggregated structures as shown schematically in Table 9 . It should be noted that many known enzymes are oligomeric.
Artificial hi-and trifunctional enzymes have been constructed and compared with the unfused enzymes catalyzing the same sequential reaction by Bulow and Mosbach (77) . The three-dimensional (3D) structure of creatinase has been determined (85) , thus enabling the interpretation of the stabilizing amino acid exchanges in the context of the structural model. This encouraged us to use creatinase as a model system to study the value of predicted stabilizing amino acid substitution(s) deduced with the aid of the 3D structure. However, all creatinase mutants designed on the assumption that a more spacefilling amino acid in an area of creatinase of low electron density might be stabifizing (e.g., by additional hydrophobic interactions)
were only as stable as the wild-type enzyme (L. RUssmann, personal communication).
To summarize, the success of random mutagenesis and screening for a mutant enzyme depends mainly on the feasibility of setting up an efficient discriminating selection and screening system for the desired phenotype. In contrast, 3D structure-based enzyme engineering is essentially more complex. Our understanding of the factors that stabilize proteins or allow for efficient catalysis is somewhat limited, although good progress is being made (86, 87).
Genetically Engineered p-Galactosidase for a New Homogeneous Immunoassay System
A novel homogeneous immunoassay system, CEDIA, has been developed on the basis of the well-known a-cornplementation reaction of E. coli /3-galactosidase (88, 89) (see Fig. 5 ). Active tetrameric f3-galactosidase is formed by spontaneous association of a short NH2-terminal /3-galactosidase fragment of -70-90 amino acids (the a-polypeptide, also termed enzyme donor, ED) and a (3-galactosidase monomer with a small deletion of up to -50 amino acids near the N}12 terminus (enzyme acceptor, EA). Ligands (haptens) can be chemically attached to the a-peptide in such a way that they do not interfere with association and enzymatic activity of /3-galactosidase. This assembly of active /3-galactosidase can be inhibited by a ligand (hapten)-speciflc antibody. Therefore, one can set up a homogeneous assay based on the competition between the ligand (analyte) in the sample and the EDligand (hapten) conjugate for the antibody. Within 5-15 miii this leads to the development of a colorimetric signal (rate of substrate hydrolysis by the enzyme) that is directly proportional to the amount of analyte present in the sample.
In the CEDIA test, genetic engineering was used for the generation and selection of appropriate ED-EA pairs with respect to (a) favorable kinetics of formation of active /3-galactosidase, EAs were then preselected by corn-plementation in vivo (E. coli expressing an appropriate ED gene). Furthermore, two E. coli overproducers were constructed for the production of the EA and the ED /3-galactosidase fragment. The small ED fragment could not be purified from E. coli host cells directly, because of proteolytic degradation inside the cells. Hence, the small ED fragment was coexpressed with the large EA fragment to form activeand stable/3-galactosidase in vivo. After purification of the active /3-galactosidase, the EA polypeptide was recovered by denaturation of the enzyme complex with 6 molIL urea.
This technology has found commercial application in clinical laboratories for the estimation of a wide range of analytes (91), including hormones (e.g., thyroxine and cortisol), vitamins (e.g., B12 and folate), and therapeutic drugs (e.g., phenytoin and digoxin).
Concluding Remarks
Enzymes derived by recombinant DNA technology are becoming more common both in industry, where they are used as biocatalysts, and in medicine, where they are used as therapeutic agents and diagnostic tools. The advantages of such enzymes include potential increased enzyme yield (up to 50% of the total cellular protein), simplified downstream processing, increased product quality, process profitability and safety (e.g., substitution for pathogenic natural source material). Use of these enzymes also has environmental advantages, such as reduced raw material, energy, and waste.
In those cases where a microbial host fails to express the enzyme efficiently or to secrete it in an enzymatically active form, in vitro renaturation of insoluble aggregated protein (e.g., from E. coli) is a possible alternative. This strategy is attractive for two of the most commonly used enzyme labels, i.e., mammalian alkaline phosphatases and plant peroxidases. It remains to be seen whether diagnostic enzymes will be as important in the future as in the past. 
